Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
11/2013
11/06/2013CN102099350B Novel herbicides
11/06/2013CN101657423B Iminipyridine derivatives and their uses as microbiocides
11/05/2013US8575394 Preparation of alpha-hydroxyketones
11/05/2013US8575370 Method for manufacturing neuraminic acid derivatives
11/05/2013US8575367 Ketal ester derivatives
10/2013
10/31/2013WO2013163262A1 Piperazine-piperidine compounds as hepatitis c virus inhibitors
10/31/2013WO2013162757A1 Cytotoxic-drug delivering molecules targeting hiv (cdm-hs), cytotoxic activity against the human immunodeficiency virus and methods of use
10/31/2013US20130289106 Cinnamic acid-based oligomers and uses thereof
10/31/2013US20130288371 Use of parthenolide derivatives as antileukemic and cytotoxic agents
10/30/2013CN103380122A Novel benzodioxole piperazine compounds
10/30/2013CN103380115A Sulfur derivatives as chemokine receptor modulators
10/30/2013CN102234268B Method for preparing ultraviolet (UV)-curable polyisocyanate modified superbranched epoxy acrylate
10/30/2013CN102206209B Method for extracting and separating soybean isoflavone monomer compounds from soybeans
10/24/2013WO2013121235A3 Process for preparation of dronedarone by removal of hydroxyl group
10/24/2013WO2012159072A4 Fluorescent molecular probes for use in assays that measure test compound competitive binding with sam-utilizing proteins
10/24/2013US20130281525 ARYL HYDROCARBON RECEPTOR (AhR) MODIFIERS AS NOVEL CANCER THERAPEUTICS
10/24/2013US20130281490 Disubstituted Beta-lactones as Inhibitors of N-Acylethanolamine Acid Amidase (NAAA)
10/23/2013EP2651931A1 Fused dihydropyrans as gpr119 modulators for the treatment of diabetes, obesity and related diseases
10/23/2013EP2651912A1 Photochromic compounds and compositions
10/23/2013EP2651911A1 Lactone compounds and materials made therefrom
10/23/2013EP2651901A1 Novel 1,2- bis-sulfonamide derivatives as chemokine receptor modulators
10/23/2013EP2651893A1 Sulfur derivatives as chemokine receptor modulators
10/22/2013US8563751 Method for manufacturing trimellitic anhydride aryl ester
10/22/2013US8563041 Therapeutic particles suitable for parenteral administration and methods of making and using same
10/22/2013US8562953 Dendritic polymers and magnetic resonance imaging contrast agent employing the same
10/17/2013WO2013155317A1 Salt form of a human hi stone methyltransf erase ezh2 inhibitor
10/17/2013US20130274283 Premature-termination-codons readthrough compounds
10/17/2013US20130273004 Substituted alkylamine derivatives and methods of use
10/16/2013EP2649067A1 Benzofurane derivatives for the treatment of hepatitits c
10/16/2013CN103354810A Photochromic compounds and compositions
10/16/2013CN101600706B Akt活性抑制剂 Akt activity inhibitor
10/15/2013US8557978 Cross-linked glycopeptide-cephalosporin antibiotics
10/10/2013WO2013151308A1 Epoxy compound having alkoxysilyl group, composition and hardened material comprising same, use for same, and production method for epoxy compound having alkoxysilyl group
10/10/2013WO2013115619A3 Novel antibacterial compound
10/09/2013EP2646425A1 Indanyloxydihydrobenzofuranylacetic acids
10/09/2013CN103347877A Methods of making fused ring compounds
10/08/2013US8552056 Biologically active taxane analogs and methods of treatment by oral administration
10/03/2013WO2013149124A1 Small molecule inhibitors of mcl-1 and uses thereof
10/03/2013WO2013148603A1 Cinnoline derivatives as as btk inhibitors
10/03/2013WO2013144098A1 New indanyloxydihydrobenzofuranylacetic acid derivatives and their use as gpr40 receptor agonists
10/03/2013WO2013144097A1 New indanyloxydihydrobenzofuranylacetic acid derivatives and their use as gpr40 receptor agonists
10/03/2013WO2013143811A1 N-cyclylamides as nematicides
10/03/2013WO2013142999A1 Synthetic process for preparation of macrocyclic c1-keto analogs of halichondrin b and intermediates useful therein
10/02/2013EP2644605A1 Method for producing optically active fluorine-containing oxeten
10/02/2013EP2644595A1 N-Cyclylamides as nematicides
10/02/2013EP2643300A1 Inhibitors of the activity of complex iii of the mitochondrial electron transport chain and use thereof for treating diseases
10/02/2013CN103339125A Pyrazole compounds as CRTH2 antagonists
10/02/2013CN103339118A Lactone compounds and materials made therefrom
10/02/2013CN102458402B Nicotinamide compounds useful as kinase modulators
09/2013
09/26/2013WO2013140347A1 Sulphonamide derivatives of benzylamine for the treatment of cns diseases
09/26/2013US20130252937 New indanyloxydihydrobenzofuranylacetic acids
09/25/2013EP2641906A1 Tofa analogs useful in treating dermatological disorders or conditions
09/25/2013EP2640806A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
09/25/2013EP2640726A1 Novel compound for organic electronic material and organic electroluminescent device using the same
09/25/2013EP2640698A1 Nampt and rock inhibitors
09/25/2013CN103328468A Alpha-7 nicotinic receptor modulators for the treatment of pain, a psychotic disorder, cognitive impairment or alzheimer's disease
09/25/2013CN102131794B 6-substituted phenoxychroman carboxylic acid derivatives
09/24/2013US8541453 Modulators of ATP-binding cassette transporters
09/19/2013WO2013138600A1 Radioprotector compounds
09/19/2013WO2013137663A1 Epoxy compound having alkoxy silyl group, composition comprising same, cured product, use thereof and method for preparing epoxy compound having alkoxy silyl group
09/19/2013US20130239852 Biobased Plasticizer and Surface Covering Employing Same
09/18/2013EP2639220A1 Indole derivatives and their use as antibiotics
09/18/2013EP2638096A2 Polyketal adducts, methods of manufacture and uses thereof
09/18/2013EP2638037A2 Polyhydroxy ketal ester adducts, methods of manufacture and uses thereof
09/18/2013EP2637659A1 Sgc stimulators
09/18/2013CN103313979A Novel compound for organic electronic material and organic electroluminescent device using the same
09/18/2013CN103313968A Nampt and rock inhibitors
09/18/2013CN103304605A Method for preparing flavonoid glycoside and stibene glucoside type compound by separating from fenugreek
09/18/2013CN103304553A 2-(propylene-2-yl)-2,3-dihydro-4-benzofuranol as well as preparation method and application thereof
09/18/2013CN102050852B 2'-O-rhamnosyl swertisin, preparation of analogues thereof, and application thereof
09/17/2013US8536189 Spiropiperidines for use as tryptase inhibitors
09/17/2013US8536166 Inhibitors of Burton's tyrosine kinase
09/12/2013WO2013134660A1 4 -hydroxy- isoquinoline compounds as hif hydroxylase inhibitors
09/12/2013WO2013134415A1 Mannose derivatives for treating bacterial infections
09/12/2013WO2013134085A1 Inhibitors of beta-secretase
09/12/2013WO2013109972A3 Therapeutic compounds
09/12/2013WO2013032960A3 Vitamin d receptor - coregulator inhibitors
09/12/2013US20130237711 Intermediates for the preparation of analogs of halichondrin b
09/12/2013US20130237536 Heterocyclic modulators of cannabinoid receptors
09/12/2013US20130237528 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
09/11/2013CN203187609U Production line for extracting silymarin
09/11/2013CN1665807B Novel physiolgically active substances
09/11/2013CN103298799A Heterocyclic compounds suitable for the treatment of dyslipidemia
09/11/2013CN103288810A Cyclopropyl derris hydrazide, and preparation method and application thereof
09/11/2013CN103288809A Puerarin monophosphate or monosulfonate derivative and preparation method thereof
09/11/2013CN102079745B Production method of silymarin
09/06/2013WO2013130855A1 Indazole derivatives
09/06/2013WO2013127789A1 Microbiocidal pyrazole derivatives
09/06/2013WO2013127768A1 Pyridine carboxamide pesticides
09/06/2013WO2013127729A1 6 - alkynyl pyridines as smac mimetics
09/04/2013EP2632918A1 Alpha-7 nicotinic receptor modulators for the treatment of pain, a psychotic disorder, cognitive impairment or alzheimer's disease
09/04/2013CN103275885A Streptomycete and its application in production of compounds having antibiotic effect
09/04/2013CN103275052A Method for synthesizing isoflavone by nickel-catalyzed Negishi cross coupling reaction at room temperature
09/04/2013CN103271904A Nitric oxide donor endothelin receptor antagonist as well as preparation method and application thereof
09/04/2013CN101679339B Method for manufacturing neuraminic acid derivatives
09/03/2013US8524720 Substituted N-(pyrazol-5-yl)-pyrrolo[3,2-D]pyrimidin-4-amine useful as protein kinase inhibitors
08/2013
08/29/2013WO2013126156A1 Nitric oxide donating selective glucocorticoid receptor agonist compounds and ophthalmic compositions
08/29/2013WO2013125732A1 Aromatic ring compound
08/28/2013EP2630141A1 Cathepsin s inhibitor compounds
08/28/2013EP2630140A1 Organic electroluminescent device
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 ... 120